Health Canada inspection
Pfizer Inc.: Health Canada inspection of Jun 30, 2017
Health Canada · GMP · rating C
Key facts
| Establishment | Pfizer Inc. |
|---|---|
| City | Rouses Point |
| Province | NY |
| Country | United States |
| Program | GMP |
| Start date | Jun 26, 2017 |
| End date | Jun 30, 2017 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.